Psychiatric adverse events during levetiracetam therapy

被引：190

作者：

Mula, M ^{[1
]}

Trimble, MR ^{[1
]}

Yuen, A ^{[1
]}

Liu, RSN ^{[1
]}

Sander, JWAS ^{[1
]}

机构：

[1] UCL, Inst Neurol, Dept Clin & Expt Epilepsy, London WC1N 3BG, England

来源：

NEUROLOGY | 2003年 / 61卷 / 05期

关键词：

D O I：

10.1212/01.WNL.0000078031.32904.0D

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

The prevalence and psychopathologic features of psychiatric adverse events (PAE) in 517 patients taking levetiracetam (LEV) were investigated. Fifty-three (10.1%) patients developed PAE. A significant association was found with previous psychiatric history, history of febrile convulsions, and history of status epilepticus, whereas lamotrigine co-therapy had a protective effect. PAE were not related to the titration schedule of LEV, and certain patients seem to be biologically more vulnerable.

引用

页码：704 / 706

页数：4

共 10 条

[1] PROPOSAL FOR REVISED CLASSIFICATION OF EPILEPSIES AND EPILEPTIC SYNDROMES [J].

不详 .

EPILEPSIA, 1989, 30 (04) :389-399

[2]

[Anonymous], 1998, FORCED NORMALIZATION

[3]

Asconape Jorge J., 2001, Epilepsia, V42, P299

[4] Levetiracetam for partial seizures - Results of a double-blind, randomized clinical trial [J].

Cereghino, JJ ;

Biton, V ;

Abou-Khalil, B ;

Dreifuss, F ;

Gauer, LJ ;

Leppik, I .

NEUROLOGY, 2000, 55 (02) :236-242

[5] A systematic review of the safety profile of levetiracetam: a new antiepileptic drug [J].

French, J ;

Edrich, P ;

Cramer, JA .

EPILEPSY RESEARCH, 2001, 47 (1-2) :77-90

[6] Efficacy and tolerability of 1000-4000 mg per day of levetiracetam as add-on therapy in patients with refractory epilepsy [J].

Grant, R ;

Shorvon, SD .

EPILEPSY RESEARCH, 2000, 42 (2-3) :89-95

[7] Levetiracetam psychosis in children with epilepsy [J].

Kossoff, EH ;

Bergey, GK ;

Freeman, JM ;

Vining, EPG .

EPILEPSIA, 2001, 42 (12) :1611-1613

[8] Long-term continuation of levetiracetam in patients with refractory epilepsy [J].

Krakow, K ;

Walker, M ;

Otoul, C ;

Sander, JWAS .

NEUROLOGY, 2001, 56 (12) :1772-1774

[9] Pyrrolidone derivatives [J].

Shorvon, S .

LANCET, 2001, 358 (9296) :1885-1892

[10] Disease modification in partial epilepsy [J].

Walker, MC ;

White, HS ;

Sander, JWAS .

BRAIN, 2002, 125 :1937-1950

← 1 →